The invention relates to compounds of the formula I
wherein the variables are as defined in the claims. The compounds are A
2A
-receptor ligands, such as antagonists, agonists, reverse agonists or partial agonists, and are useful in the treatment of neurological and psychiatric disorders where an A
2A
-receptor is implicated.
The invention relates to compounds of the formula I
wherein the variables are as defined in the claims. The compounds are A
2A
-receptor ligands, such as antagonists, agonists, reverse agonists or partial agonists, and are useful in the treatment of neurological and psychiatric disorders where an A
2A
-receptor is implicated.
[EN] N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES<br/>[FR] DERIVES DE N-THIAZOLE-2-YLE-BENZAMIDE
申请人:LUNDBECK & CO AS H
公开号:WO2005039572A1
公开(公告)日:2005-05-06
The invention relates to N-thiazol-2-yl-benzamide derivatives of the formula I in the description wherein the variables are as defined in the claims. The compounds are A2A-receptor ligands, such as antagonists, agonists, reverse agonists or partial agonists, and are useful in the treatment of neurological and psychiatric disorders where an A2A-receptor is implicated.